Ocean Biomedical Company Description
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.
It develops an antibody therapeutic product candidate inhibiting Chi3l1, a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1, and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of idiopathic pulmonary fibrosis and Hermansky-Pudlak syndrome.
The company is also developing three product candidates based on the whole proteome differential screening target discovery platform, including a malaria vaccine candidate against plasmodium falciparum Schizont Egress Antigen-1 (PfSEA-1) and/or against plasmodium falciparum Glutamic Acid Rich Protein (PfGARP); a humanized mAb malaria therapeutic candidate targeting PfGARP; and a small molecule malaria product candidate targeting PfGARP.
It has a license agreement with Elkurt, Inc. for FRG Antibodies, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies.
The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.
| Country | United States |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | M. Berrey |
Contact Details
Address: 55 Claverick Street Providence, Delaware 02903 United States | |
| Phone | 401 444 7375 |
| Website | oceanbiomedical.com |
Stock Details
| Ticker Symbol | OCEA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US67644C1045 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Inderjote Kathuria M.B.A., M.D. | Chief Strategy Officer |
| Dr. Chirinjeev Baboo Kathuria M.B.A., M.D. | Founder and Executive Chairman of the Board |
| Dr. Jack A. Elias M.D. | Founder, Chairman of Scientific Advisory Board |
| Dr. Jonathan Kurtis M.D., Ph.D. | Founder, Chairman of Scientific Advisory Board and Director |
| Jolie G. Kahn C.P.A., Esq. | Chief Financial Officer |
| Robert John Sweeney | Chief Accounting Officer and Assistant Secretary |